The PPWR Regulation (EU) 2025/40 applies from 12 August 2026 · Try it free →
PPWR by sector

What PPWR obligations do pharmaceutical manufacturers have?

Author: Marius Cristian Brînzea, Managing Partner Circulad'OR · Updated 19 November 2026

Legal basis: Regulation (EU) 2025/40, Art. 6, 7, 15
The short answer

Like any packaging, medicine and medical device packaging needs PPWR technical documentation, a PPWR declaration of conformity and an identification element from 12 August 2026; however, the Regulation exempts the immediate packaging of medicinal products and the contact-sensitive packaging of medical devices from the recyclability and recycled-content requirements of 2030.

What already applies from 2026?

The PPWR technical documentation, the PPWR declaration of conformity, the heavy-metal report and the identification element for each packaging type.

The exemptions in the Regulation concern the 2030 requirements (recyclability, recycled content), not the 2026 documents.

What exemptions exist?

The immediate packaging of medicinal products, the outer packaging needed for the quality of the medicinal product and contact-sensitive packaging for medical devices and in vitro diagnostics are exempt from the recyclability requirements (Art. 6(11)) and from the recycled-content thresholds (Art. 7(4)).

The exemptions concern the packaging that protects the medicine or the device; otherwise, the box and the transport packaging follow the general rules. The Commission reviews the recyclability exemptions by 1 January 2035 (Art. 6(12)).

How is the declaration made for a box with several components?

Per packaging: the blister, the vial, the box and the leaflet are treated separately; the leaflet is not packaging.

A box with 5 ampoules is a single sales unit but contains several packagings (the ampoules, the tray, the box), each with its own documentation or with a declaration per sales unit, where applicable.

Does the serialisation code replace PPWR identification?

Not automatically. The serialisation code identifies the product; the identification in Art. 15(5) must lead to the packaging and its technical documentation.

The internal code of the packaging or another element on the packaging, linked to the technical documentation, meets the requirement without changing the serialisation system.

What Yvora does

Yvora has the declaration-per-sales-unit module, used by pharmaceutical manufacturers for boxes with several components, and automatically separates the leaflet (which is not packaging) from the packaging components.

Frequently asked questions

Does a blister need a heavy-metal report?

Yes. The 100 mg/kg limit in Art. 5 applies to all packaging, including blisters.

Are food supplements treated like medicines?

No. Food supplements are food: the rules for food packaging apply, including the PFAS restriction.

Do the exemptions also apply to medical devices?

Yes, for the contact-sensitive packaging of medical devices and in vitro diagnostics (Art. 6(11) and Art. 7(4)).

Sources: Regulation (EU) 2025/40 on packaging and packaging waste (EUR-Lex) · European Commission - PPWR guidance and FAQ (30.03.2026)

General information on Regulation (EU) 2025/40, not legal advice on a specific case. Final compliance remains the responsibility of the economic operator.

Try it on your own packaging

Free 48-hour demo, no card: packaging sheet, assessment, PPWR technical documentation and PPWR declaration of conformity.

Try Yvora for free →